Life360, Inc. (LIF) director pre-plans 4,000-share sale via 10b5-1 plan
Rhea-AI Filing Summary
Life360, Inc. director John Philip Coghlan reported pre-planned sales of a total of 4,000 shares of common stock on August 3, 2026 by the John Coghlan Living Trust under a Rule 10b5-1 trading plan adopted on December 8, 2025. The trust sold 1,400 shares at a weighted average price of $54.66 (range $53.83–$54.80) and 2,600 shares at a weighted average price of $54.90 (range $54.89–$54.95). After these transactions, Coghlan holds 5,676 shares directly, including 4,840 restricted stock units, and 55,494 shares indirectly through a 2025 Grantor Retained Annuity Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,000 shares
Net Sell
4 txns
Insider
COGHLAN JOHN PHILIP
Role
Director
Sold
4,000 shs ($219K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock F1, F2 | 1,400 | $54.66 | $77K |
| Sale | Common stock F1, F3 | 2,600 | $54.90 | $143K |
| holding | Common stock F4 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common stock — 20,431 shares (Indirect, Held by the John Coghlan Living Trust);
Common stock — 5,676 shares (Direct);
Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $53.83 to $54.80, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $54.89 to $54.95, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- F4. Includes 4,840 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
Key Figures
Shares sold (first tranche): 1400.0000 shares
Weighted average price (first tranche): $54.6600 per share
Shares sold (second tranche): 2600.0000 shares
+5 more
8 metrics
Shares sold (first tranche)
1400.0000 shares
Common stock sold on August 3, 2026 by John Coghlan Living Trust
Weighted average price (first tranche)
$54.6600 per share
Open-market sales with prices from $53.83 to $54.80
Shares sold (second tranche)
2600.0000 shares
Common stock sold on August 3, 2026 by John Coghlan Living Trust
Weighted average price (second tranche)
$54.9000 per share
Open-market sales with prices from $54.89 to $54.95
Total shares sold
4000 shares
Net common shares sold in reported transactions
Direct holdings after transactions
5676.0000 shares
Includes 4,840 restricted stock units reported as direct holdings
Indirect GRAT holdings after transactions
55494.0000 shares
Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Restricted stock units included
4,840 units
Each RSU represents a contingent right to one common share upon vesting
Key Terms
Rule 10b5-1 trading plan, weighted average price, restricted stock units, Grantor Retained Annuity Trust
4 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes 4,840 restricted stock units, each of which represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Life360 (LIF) report for John Philip Coghlan?
John Philip Coghlan reported selling 4,000 shares of Life360 common stock on August 3, 2026 through the John Coghlan Living Trust. The sales were disclosed as open-market transactions executed under a Rule 10b5-1 trading plan adopted on December 8, 2025.
Were the Life360 (LIF) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on December 8, 2025. This pre-arranged written plan sells shares automatically using a predetermined formula when the insider is not aware of material nonpublic information.
What is the nature of the restricted stock units reported for Life360 (LIF)?
Coghlan's direct holdings include 4,840 restricted stock units (RSUs), each representing a contingent right to receive one share of Life360 common stock upon vesting. These RSUs are included within the reported 5,676 direct shares after the transactions.